投稿信息
稿件收录要求
Published by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 1172-7047.
CNS Drugs is your source for essential information about the treatment of psychiatric and neurological disorders. The journal takes a bench to bedside approach, covering topics from basic pharmacology and disease pathology, to drugs in development and guidelines for clinical practice. CNS Drugs' structured program of peer reviewed articles written by international experts provides essential reading each month for pharmaceutical industry clinical researchers, clinical pharmacologists, drug information pharmacists and specialist clinicians in the CNS area.
CNS Drugs为研究人员和医疗保健专业人士提供了有关用于治疗神经和精神疾病的药物疗法的最重要方面的重要信息。
该期刊通过评论和原创研究文章的计划，讨论了与这些疾病的药物治疗有关的主要问题，包括主要类别药物的药理学、功效和副作用；新开发药物和药物类别的信息；对神经和精神疾病病因的最新研究的治疗意义；以及特定临床情况的实际管理。
作为一本混合型期刊，《CNS Drugs》不向采用传统订阅式出版方式的作者收取出版费用，但如果作者愿意或其资助者要求，则提供以开放获取方式出版已接受文章的选项
